VeriSign, Inc.
VRSN · NASDAQ
Analyst ratings
buy · 3 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| June 18, 2026 | JP Morgan | Maintains | Neutral | $308.00 |
| June 1, 2026 | JP Morgan | Maintains | Neutral | $285.00 |
| April 24, 2026 | Citigroup | Maintains | Buy | $320.00 |
| April 24, 2026 | JP Morgan | Maintains | Neutral | $278.00 |
| April 24, 2026 | Baird | Maintains | Outperform | $355.00 |
| April 2, 2026 | Citigroup | Maintains | Buy | $295.00 |
| February 9, 2026 | Citigroup | Maintains | Buy | $280.00 |
| January 6, 2026 | JP Morgan | Maintains | Neutral | $271.00 |
AI-driven domain registration growth vs. AI disruption risk
VeriSign is well-positioned to benefit from AI-driven domain registration growth, with Q1 2026 earnings beating expectations at $2.34 EPS and full-year revenue guidance raised to $1.730–$1.745 billion. The company's dominant registry position for .com and .net domains provides a structural tailwind as AI expands the digital economy.
AI may ultimately disrupt VeriSign's core domain registry business by reducing the need for traditional web addresses through AI-generated interfaces and alternative digital identities. Analysts caution that investors should monitor AI disruption potential as a meaningful long-term risk to domain demand.
Contract renewal uncertainty and regulatory risk
VeriSign's monopoly-like control over .com and .net registries, backed by U.S. government support and high customer switching costs, gives it significant leverage in contract renewals. Diamond Hill Mid Strategy noted the company benefits from proprietary technology and disciplined capital allocation regardless of near-term regulatory pressures.
Contract renewal uncertainty remains a key overhang for VeriSign, with analysts highlighting legal and regulatory risks as material concerns. The consensus price target implies limited near-term upside, and cautious monitoring of litigation outcomes and renewal terms is considered essential before taking a more constructive position.
Valuation premium and upside potential
Multiple Wall Street firms have raised their price targets, with Robert W. Baird setting a $355 target and Citigroup raising its target to $320 with a buy rating. The consensus target of $325.25 represents approximately 17.6% upside from recent trading levels, supported by strong net income margins of nearly 50% and consistent revenue growth.
VeriSign trades at a roughly 20% premium to peers, and JPMorgan maintained a neutral rating with a comparatively modest $308 target. Seeking Alpha analysts suggest a Hold rating is more appropriate below $200, citing high valuation multiples and stable but limited growth that may not justify the current price.